EMMETT ROBINSON
Allopathic & Osteopathic Physicians|Internal Medicine SOUTH HOLLAND, IL NPI 1609220409
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine IL Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$424.47
- Category: General Payments
- Program years: PY2019–2020
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $126.58 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $126.58 | 8 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.46 | 3 |
| Lilly USA, LLC | $30.60 | 2 |
| Astellas Pharma US Inc | $18.82 | 1 |
| Novo Nordisk AS | $14.47 | 1 |
| Acerta Pharma LLC | $11.23 | 1 |
By program year
Records — PY2020 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 718375051 | Astellas Pharma US Inc | $18.82 | 01/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 720962679 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.12 | 07/31/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 720962683 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16.13 | 01/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 720962689 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15.21 | 01/15/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 728415367 | Lilly USA, LLC | $15.52 | 02/28/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 728432569 | Lilly USA, LLC | $15.08 | 02/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736366689 | AstraZeneca Pharmaceuticals LP | $11.23 | 02/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744623501 | Novo Nordisk Inc | $14.47 | 02/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.